Re: [QUAD-L] test

2013-06-03 Thread wheelchair
I don't think so, but I got it via the Quad-List
 
Best Wishes
 
 
In a message dated 6/3/2013 11:27:00 A.M. Central Daylight Time,  
da...@immortaldesigns.co writes:

Does this work  yet?


RE: [QUAD-L] test

2013-06-03 Thread Danny Espinoza
Cool it's not blocking me anymore then :D My messages would never make it to
the quad list before and I would get an email from the server saying it had
been blocked.

 

From: wheelch...@aol.com [mailto:wheelch...@aol.com] 
Sent: Monday, June 03, 2013 9:59 AM
To: da...@immortaldesigns.co; quad-list@eskimo.com
Subject: Re: [QUAD-L] test

 

I don't think so, but I got it via the Quad-List

 

Best Wishes

 

In a message dated 6/3/2013 11:27:00 A.M. Central Daylight Time,
da...@immortaldesigns.co mailto:da...@immortaldesigns.co  writes:

Does this work yet?



Re: [QUAD-L] test

2013-06-03 Thread Don Price
Welcome back, Danny :)



 From: Danny Espinoza da...@immortaldesigns.co
To: wheelch...@aol.com; quad-list@eskimo.com 
Sent: Monday, June 3, 2013 10:10 AM
Subject: RE: [QUAD-L] test
 


Cool it’s not blocking me anymore then :D My messages would never make it to 
the quad list before and I would get an email from the server saying it had 
been blocked.
 
From:wheelch...@aol.com [mailto:wheelch...@aol.com] 
Sent: Monday, June 03, 2013 9:59 AM
To: da...@immortaldesigns.co; quad-list@eskimo.com
Subject: Re: [QUAD-L] test
 
I don't think so, but I got it via the Quad-List
 
Best Wishes
 
In a message dated 6/3/2013 11:27:00 A.M. Central Daylight Time, 
da...@immortaldesigns.co writes:
Does this work yet?

RE: [QUAD-L] test

2013-06-03 Thread Danny Espinoza
Thank you! :D

 

From: Don Price [mailto:donpric...@yahoo.com] 
Sent: Monday, June 03, 2013 10:34 AM
To: da...@immortaldesigns.co; wheelch...@aol.com; quad-list@eskimo.com
Subject: Re: [QUAD-L] test

 

Welcome back, Danny :)

 

  _  

From: Danny Espinoza da...@immortaldesigns.co 
mailto:da...@immortaldesigns.co 
To: wheelch...@aol.com mailto:wheelch...@aol.com ; quad-list@eskimo.com 
mailto:quad-list@eskimo.com  
Sent: Monday, June 3, 2013 10:10 AM
Subject: RE: [QUAD-L] test

 

Cool it’s not blocking me anymore then :D My messages would never make it to 
the quad list before and I would get an email from the server saying it had 
been blocked.

 

From: wheelch...@aol.com mailto:wheelch...@aol.com  
[mailto:wheelch...@aol.com] 
Sent: Monday, June 03, 2013 9:59 AM
To: da...@immortaldesigns.co mailto:da...@immortaldesigns.co ; 
quad-list@eskimo.com mailto:quad-list@eskimo.com 
Subject: Re: [QUAD-L] test

 

I don't think so, but I got it via the Quad-List

 

Best Wishes

 

In a message dated 6/3/2013 11:27:00 A.M. Central Daylight Time, 
da...@immortaldesigns.co mailto:da...@immortaldesigns.co  writes:

Does this work yet?

 



Re: [QUAD-L] Van, computer, now throat!

2013-06-03 Thread greg
Fuel injection, not carb.
I guess I still think of motors from when I actually touched one :-)

Greg

 I guess we are both winners, wieners, whiners and whistles.  The
 van had a carb or fuel injection?   Best Wishes

 In a message dated 5/30/2013 3:46:21 P.M. Central Daylight Time,
 g...@eskimo.com writes:

 Tie, I
 guess.
 I don't have the paperwork here, but it was an electrical thing
 with a carburetor and causing a fuel issue when it got hot. if I
 find the paperwork, I'll post the exact issue. Greg

 PS. Post on the
 quadlist what was wrong with your van. Wheelchair

 said electrical, I
 said fuel. I want to take a victory lap.
 LOL



Re: [QUAD-L] test

2013-06-03 Thread Mike Mills
All good here!





 From: Danny Espinoza da...@immortaldesigns.co
To: wheelch...@aol.com; quad-list@eskimo.com 
Sent: Monday, June 3, 2013 1:10 PM
Subject: RE: [QUAD-L] test
 


Cool it’s not blocking me anymore then :D My messages would never make it to 
the quad list before and I would get an email from the server saying it had 
been blocked.
 
From:wheelch...@aol.com [mailto:wheelch...@aol.com] 
Sent: Monday, June 03, 2013 9:59 AM
To: da...@immortaldesigns.co; quad-list@eskimo.com
Subject: Re: [QUAD-L] test
 
I don't think so, but I got it via the Quad-List
 
Best Wishes
 
In a message dated 6/3/2013 11:27:00 A.M. Central Daylight Time, 
da...@immortaldesigns.co writes:
Does this work yet?

[QUAD-L] Fwd: 6-13 SCI Webcast- Advances in Research for Recovery

2013-06-03 Thread DAANOO


 
  

 From: ju...@bu.edu
To: daa...@aol.com
Sent: 6/3/2013 8:52:41 P.M.  Central Daylight Time
Subj: 6-13 SCI Webcast- Advances in Research for  Recovery


  
 
Don’t  forget to register for the June 13th webcast! 
 



 

Knowledge in Motion
SCI  Webcast Series

For  individuals living with spinal cord injury, 
their  caregivers,  healthcare professionals 

New  Advances in Research 
for  Recovery after SCI 

Presented  by 

Jeffrey  D. Macklis, MD 
Harvard  Stem Cell Institute 
Harvard  University 
Harvard  Medical School  
Lisa  McKerracher, Ph.D. 
BioAxone  BioSciences, Inc.   
Frank  Reynolds 
InVivo  Therapeutics 

Angus  McQuilken 
Mass.  Life Sciences Center 

Thursday, June  13, 2013 
6:30-8:00 PM  Eastern Time 
Register to  attend _Free  Online Webcast and Live Chat_ 
(http://www.us6.list-manage.com/track/click?u=d2abecee0caf6876e559a54ecid=d7edd4bc8de=905798e
3fb)  
(http://www.bu.edu/nerscic/webcast-reg/)   
or  contact: 
Judi Zazula  at _judiz@bu.edu_ (mailto:ju...@bu.edu)  
617-638-7314 
866-607-1804  (toll-free) 
Attendees will  be able to: 
·   Understand  how the corticospinal nerve injury contributes to 
SCI disabilities, and  how it might be repaired. 
·   Understand  what new treatment options based on biomaterials 
will be available for  SCI patients in the near future. 
·   Learn about the 10-year,  $1-billion MA Life Sciences 
Initiative and its relevance to the SCI  community. 
·   Learn about  the current state of drug development to treat 
SCI. 

~ 

About this  month’s speakers and their presentations: 
Jeffrey  Macklis, MD, Harvard  Stem Cell institute, Professor of Stem Cell 
and Regenerative Biology at  Harvard University, and Professor of Neurology 
and Neurosurgery at  Harvard Medical School, will discuss the basic neurons 
and circuitry  that connect the brain to the spinal cord.  He will talk 
about the  kinds of nerve injuries that are central to loss of muscle strength 
in  SCI.  Repair, regeneration, and/or replacement of these neurons by  
developmental and stem cell biology might provide useful, real-world  therapies 
for real people who have lost motor function and  bowel/bladder control due 
to SCI. Dr. Macklis will highlight a  brand new set of approaches that his 
lab is using to pursue this  goal. 
Lisa  McKerracher, PhD, Founder,  BioAxone Biosciences, will present on 
some studies showing that neurons  in the spinal cord have the capacity for 
regeneration and repair.  She will also describe BioAxone’s efforts to develop 
a drug called  Cethrin™.  Cethrin is new therapeutic protein in Phase II 
clinical  development for the treatment of acute spinal cord injury.  It has  
shown exceptional promise in promoting motor recovery in quadriplegic  
patients. BioAxone Biosciences Inc. is a privately owned American  Corporation 
with a focus on bringing drugs to market for unmet medical  needs. 
Angus  McQuilken, Vice  President for Communications  Marketing at the 
Massachusetts Life  Sciences Center,  will present on the investments being 
made by the  Massachusetts Life Sciences Center that relate to SCI research and 
 patient treatment.  He will talk about the state’s 10-year,  $1-billion 
Life Sciences Initiative and its relevance to the SCI  community.  The 
Massachusetts Life Sciences Center is a  quasi-public agency of the 
Commonwealth of 
Massachusetts. The Center’s  mission is to create jobs in the life sciences 
and support vital  scientific research that will improve the human 
condition. 
Frank  Reynolds, Co-Founder,  InVivo Therapeutics, will talk about the 
relationship of biomaterials to  SCI treatments.  Whether minimizing secondary 
injury in the weeks  after the primary injury, or supporting neuroplasticity 
during the  patient’s recovery, biomaterial based interventions led by  
neuroscientists and chemical engineers from MIT are providing new ideas  on how 
SCI patients will be treated in the near future. InVivo’s  technologies 
integrate multiple strategies involving biomaterials, FDA  approved drugs, 
growth factors, and human neural stem cells. Mr.  Reynolds will discuss these 
technologies as well as their impact on SCI patients. 
~ 

New England  Regional Spinal Cord Injury Center 
_www.bu.edu/nerscic_ 
(http://www.us6.list-manage.com/track/click?u=d2abecee0caf6876e559a54ecid=e7cd86bfade=905798e3fb)
  









Sent to daa...@aol.com — _why  did I get this?_ 
(http://www.us6.list-manage1.com/about?u=d
2abecee0caf6876e559a54ecid=f318459fc7e=905798e3fbc=442d633474)  
_unsubscribe  from this list_ 
(http://www.us6.list-manage2.com/unsubscribe?u=d2abecee0caf6876e559a54ecid=f318459fc7e=905798e3fbc=442d633474)
  | 
_update  subscription preferences_ 
(http://www.us6.list-manage.com/profile?u=d2abecee0caf6876e559a54ecid=f318459fc7e=905798e3fb)
  
New England Regional Spinal Cord  Injury Center · BUMC · 715 Albany Street, 
T5W · Boston, MA 02118